Company Filing History:
Years Active: 1994-2003
Title: The Innovations of Martha Jacoba Willemse
Introduction
Martha Jacoba Willemse is a notable inventor based in Nijmegen, Netherlands. She has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for feline diseases. With a total of 5 patents to her name, her work has had a profound impact on the health and well-being of cats.
Latest Patents
Willemse's latest patents include groundbreaking innovations such as a vector vaccine of recombinant feline herpesvirus. This invention focuses on a Feline Herpesvirus (FHV) mutant that incorporates a heterologous gene or foreign DNA into a section of the FHV genome. The vector vaccine is designed to express a heterologous polypeptide derived from a feline pathogen, which induces an immune response in an inoculated host against both FHV and the feline pathogen. Another significant patent is the recombinant feline herpesvirus vaccine, which also involves a mutant FHV with a heterologous gene introduced into its genome. This vaccine aims to elicit an adequate immune response against both FHV and the associated feline pathogen.
Career Highlights
Throughout her career, Willemse has worked with prominent companies such as Akzo Nobel N.V. and Akzo N.V. Her experience in these organizations has contributed to her expertise in the field of veterinary vaccines.
Collaborations
Willemse has collaborated with notable individuals in her field, including Paulus Jacobus Sondermeijer and Lesley Nicolson. These partnerships have likely enhanced her research and development efforts.
Conclusion
Martha Jacoba Willemse's contributions to veterinary medicine through her innovative patents have significantly advanced the field. Her work continues to influence the development of effective vaccines for feline diseases, ensuring better health outcomes for cats worldwide.